Compaan Design releases HotSpot Parallelizer for ISO C; Philips Healthcare reports VHDL productivity boosts.

Product launch at DAC on June 13th 2010 on Booth N° 368.

Amsterdam, the Netherlands - May 18th 2010

Compaan Design releases the Compaan HotSpot Parallelizer for ISO C, supporting x86-multicore runtime verification and Xilinx FPGA code generation. This product integrates Compaan Design’s parallelization, streaming and mapping technology with ACE’s industrial quality CoSy compiler development framework.

The Compaan HotSpot Parallelizer translates C-code hotspots to data streaming Kahn Process Networks that robustly and efficiently utilize highly parallel heterogeneous multicore chip architectures.

“Needs for low energy and high computational throughput are increasingly driving the migration of legacy/certified embedded applications to heterogeneous multicore. These architectures are complex. Successful migration requires workflow iterations of application parallelization, code compilation and system verification,” said John van Brummen, Chief Commercial Officer of Compaan Design.

“Today, we release the Compaan HotSpot Parallelizer. This is an important first step towards a full-fledged Compaan Design workflow solution with: effective and robust parallelization of ISO C code, industrial quality code generation for state-of-the-art multicore architectures, and business value product HW/SW lifecycle support.
Our product is already in use by several early adopters. This gives us invaluable technical feedback and application experience. One of Compaan Design’s early adopters is Philips Healthcare.”

“Philips Healthcare has successfully applied the Compaan Design workflow on our advanced digital image processing filters,” said Rens Rugebregt, Development Manager FXD at Philips Healthcare. “We reduced months of VHDL design effort to just two days by using Compaan Design’s innovative product.
Philips Healthcare successfully parallelized image filter C-code and got high quality VHDL results. Results that easily, reliably, and verifiably integrate within our FXD cardiovascular product line.
We experienced that the Compaan Design tool works entirely in tandem with 3rd party C-to-VHDL tools by integrating accelerated functions into an automatically generated system communication framework. This is a big plus.”

About Compaan Design

Compaan Design develops technology for hotspot parallelization of legacy/certified ISO C applications. It offers innovative products that reliably compile and scale to state-of-the-art silicon with multi-billion transistors such as x86 multicore, MPSoC and FPGA.

The Compaan Design workflow guides step-by-step parallelization towards improved energy efficiency and computational throughput. Parallelism is exploited for streaming data and increased architecture utilization. Exact dataflow analysis guarantees correctness and robustness of application execution. Code generation is heterogeneous and supports flexible HW/SW codesign. It is a perfect solution for today’s MPSoCs composed of DSPs, FPGAs and microprocessors. It easily retargets to customized processors and IP blocks.

More information on Compaan Design is available at www.compaandesign.com.

About Philips Healthcare

Royal Philips Electronics of the Netherlands is one of the world's biggest electronics companies and Europe's largest, with sales of € 23.2 bln. in 2009. It focuses on the three interlocking domains of healthcare, lifestyle and technology and has 116,000 employees in more than 60 countries. Philips is globally number 1 in medical diagnostic imaging and patient monitoring, lighting, shavers and among the world’s top-3 consumer electronics companies. Dow Jones has confirmed Philips’ leadership in sustainability on the global and European cyclical goods markets.

Sales of Philips’ Healthcare Division amounted to € 7.9 bln in 2009. In the healthcare area Philips’ innovation revolves around improving the quality and efficiency of healthcare through a focus on care cycles. Central to care cycle thinking is a patient-centric approach that optimizes healthcare delivery for all the major diseases. In Philips Healthcare, over 12% of systems sales are invested in R&D, in which the Netherlands is taking a primary position. The last 5 years have shown market share gains and strengthening of its global leadership position for many products, margin expansion and enhancement of its competitive position with key acquisitions and partnerships. These partnerships mainly focus on broadening and improving the innovation reach for Philips Healthcare.

For more information on Philips Healthcare, please see: www.medical.philips.com.

-END-

TRADEMARKS: